Open Access

Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis

  • Authors:
    • Zhongkang Li
    • Yibin Liu
    • Yanpeng Tian
    • Qian Li
    • Wenxin Shi
    • Jingkun Zhang
    • Huihui Zhang
    • Yi Tan
    • Shuangshuang Yang
    • Tao Yang
    • Xianghua Huang
    • Yanfang Du
  • View Affiliations

  • Published online on: August 23, 2023     https://doi.org/10.3892/ijmm.2023.5297
  • Article Number: 94
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Prolonging the reproductive lifespan is beneficial for preserving the physical and psychological health of women. The transplantation of mesenchymal stem cell (MSC)‑derived exosomes (MSC‑Exos) has been reported to be a promising regenerative therapeutic strategy for restoring the function of aging ovaries. The present study thus evaluated the therapeutic efficacy of exosomes derived from human umbilical cord‑MSCs (hUCMSC‑Exos) in a mouse model of natural ovarian aging (NOA), and further investigated the role of exosomal microRNAs (miRNAs/miRs) in the mechanisms of this creative therapy. Specifically, following the administration of hUCMSC‑Exos in mice with NOA, ovarian function was found to improve, as indicated by the restoration of follicle numbers and hormone levels. These exosomes were found to exhibit the ability to inhibit PTEN expression and suppress apoptosis both in vivo and in vitro. Subsequently, miRNA sequencing of the exosomes was performed, following which bioinformatics analysis was used to identify the highly expressed miRNAs that are capable of targeting PTEN expression. Through high‑throughput sequencing and molecular analyses, miR‑21‑5p was found to be the highest in ranking in terms of expression, suggesting that hUCMSC‑Exos can preserve ovarian function by suppressing PTEN expression to inhibit apoptosis by delivering miR‑21‑5p. On the whole, the results of the present study suggest that the application of exosomes can be used to restore ovarian function in mice with NOA. These positive findings also suggest that the transplantation of exosomes derived from MSCs holds promise as an agent against ovarian aging.
View Figures
View References

Related Articles

Journal Cover

October-2023
Volume 52 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Liu Y, Tian Y, Li Q, Shi W, Zhang J, Zhang H, Tan Y, Yang S, Yang T, Yang T, et al: Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis. Int J Mol Med 52: 94, 2023
APA
Li, Z., Liu, Y., Tian, Y., Li, Q., Shi, W., Zhang, J. ... Du, Y. (2023). Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis. International Journal of Molecular Medicine, 52, 94. https://doi.org/10.3892/ijmm.2023.5297
MLA
Li, Z., Liu, Y., Tian, Y., Li, Q., Shi, W., Zhang, J., Zhang, H., Tan, Y., Yang, S., Yang, T., Huang, X., Du, Y."Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis". International Journal of Molecular Medicine 52.4 (2023): 94.
Chicago
Li, Z., Liu, Y., Tian, Y., Li, Q., Shi, W., Zhang, J., Zhang, H., Tan, Y., Yang, S., Yang, T., Huang, X., Du, Y."Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis". International Journal of Molecular Medicine 52, no. 4 (2023): 94. https://doi.org/10.3892/ijmm.2023.5297